HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Götz Selected Research

Radioimmunotherapy

6/2002[Initial experiences with adjuvant locoregional radioimmunotherapy using 131I-labeled monoclonal antibodies against tenascin (BC-4) for treatment of glioma (WHO III and IV)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Götz Research Topics

Disease

2Neoplasms (Cancer)
02/2015 - 06/2002
2Fatigue
11/2014 - 06/2012
1Skin Neoplasms (Skin Cancer)
02/2015
1Glioma (Gliomas)
06/2002
1Residual Neoplasm
06/2002
1Male Infertility (Male Sterility)
01/2000
1Astrocytoma (Pilocytic Astrocytoma)
01/2000
1Hemianopsia (Bitemporal Hemianopsia)
01/2000

Drug/Important Bio-Agent (IBA)

2polyisobutyleneIBA
11/2014 - 06/2012
2Biocompatible Materials (Biomaterials)IBA
11/2014 - 06/2012
1SootIBA
11/2014
1Silicone Elastomers (SE 30)IBA
06/2012
1Biopolymers (Biopolymer)IBA
06/2012
1AntibodiesIBA
06/2002
1TenascinIBA
06/2002
1Radioisotopes (Radionuclides)IBA
06/2002
1Monoclonal AntibodiesIBA
06/2002
1bovine growth hormoneIBA
01/2000

Therapy/Procedure

2Therapeutics
02/2015 - 06/2002
2Radiotherapy
06/2002 - 01/2000
1Drug Therapy (Chemotherapy)
06/2002
1Radioimmunotherapy
06/2002